- Global Pharma News & Resources

The Biopreservation Market 2018: Market Size, Share & Trends Analysis by Product, Application and Cell Provider (2012-2022) -

The "Biopreservation Market Size, Share & Trends Analysis Report By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine, Bio-banking, Drug Discovery), By Cell Provider, And Segment Forecasts, 2012 - 2022" report has been added to's offering.

The global biopreservation market size is expected to reach USD 8.93 billion by 2022, exhibiting a 17.3% CAGR during the forecast period. Rising demand for advanced preservation methods and constantly increasing healthcare spending is anticipated to fuel growth potential in future. Hospitals, pharmaceutical companies, and biotechnology firms are increasingly adopting systems for in-house storage of samples and this is anticipated to provide a significant boost to the market. Surging R&D investments by major companies and research communities striving to improve product development capabilities is also presenting the market with immense potential. Technological advancements such as advent of virtual bio-banks, which is predicted to witness a significant upsurge in the application, is also resulting in market progression. In addition, increasing preference for maintaining repositories for biological specimens, for application in organ transplantation and regenerative medicine, has benefited the market. Presence of government initiatives such as International Society of Biological and Environmental Repositories to enhance bio-banking and preservation standards and practices is also broadening the scope for growth over the coming years.

Key Findings

  • In 2014, equipment captured the dominant share by product owing to growing demand from bio-banks. High preservation costs of biological specimens has also benefited this segment.
  • The media segment, on the other hand, is predicted to witness exponential CAGR during the coming years as a result of wide adoption in regenerative medicine.
  • In 2014, bio-banking captured a substantial share in terms of application owing to growing number of tissue and organ transplantations and high awareness levels with respect to bio-banking.
  • Regenerative medicine, on the other hand, is anticipated to register the highest CAGR owing to major investments by public and private healthcare organizations in research focused on restorative therapy.
  • By cell provider, tumor cells captured the largest share in terms of volume in 2014, as a consequence of extensive application in R&D and treatment of cancers with high prevalence.

Topics Covered

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Bio-preservation Industry Outlook

Chapter 4. Bio-preservation Product Outlook

Chapter 5. Bio-Preservation Application Outlook

Chapter 6. Bio-Preservation Cell Providers Outlook

Chapter 7. Bio-preservation Regional Outlook

Chapter 8. Competitive Landscape

  • BioCision, LLC
  • Biomatrica, Inc.
  • BioLife Solutions, Inc.
  • Chart MVE Biomedical
  • LabVantage Solutions, Inc.
  • Atlanta Biologics Inc.
  • Taylor-Wharton Cryogenics LLC
  • Panasonic Corporation
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • VWR International, LLC

For more information about this report visit

View source version on

Editor Details

Last Updated: 07-Nov-2018